{Reference Type}: Journal Article
{Title}: Critical reappraisal of short-acting bronchodilators for pediatric respiratory diseases.
{Author}: Licari A;Manti S;Mastellone F;Miraglia Del Giudice M;Marseglia GL;Tosca MA; ;
{Journal}: Ital J Pediatr
{Volume}: 50
{Issue}: 1
{Year}: 2024 May 23
{Factor}: 3.288
{DOI}: 10.1186/s13052-024-01675-0
{Abstract}: Short-acting bronchodilators are a class of medications commonly used to treat asthma, chronic obstructive pulmonary disease, and other respiratory conditions. The use of these medications has evolved over time as we have gained a better understanding of their effectiveness and safety in the pediatric population. This comprehensive review synthesizes the current understanding of short-acting β2-agonists and short-acting anticholinergics in children. It addresses indications, contraindications, safety considerations, and highlights areas where further research is needed to guide the most effective use of short-acting bronchodilators.